Web Images Videos Maps News Shopping Gmail more »
Help | Sign in
Go to Google Groups Home
   
Discussions for Tongjitang Chinese Medicines Co. View all discussions
My starred discussions
My profile

  Phase III trial data of a small cap company's upcoming obesity drug
Only 1 message in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
sneha  
View profile  
 More options Jul 1, 8:06 am
From: sneha <chhajer.sn...@yahoo.com>
Date: Wed, 1 Jul 2009 05:06:00 -0700 (PDT)
Subject: Phase III trial data of a small cap company's upcoming obesity drug
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
Small cap company to release Phase 3 data on their Obesity drug.  If
results are good, it will result in huge interest in the company and
its stock.  To read about which company, what drug, how it targets
obesity, how its different from existing drugs targeting obesity,
estimated market penetration of approved, etc., get a FREE report at:
http://www.newbiomedicine.com

    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  Upcoming presentation of a small cap company's Alzheimer's drug data in July   Upcoming Phase 3 data of Obesity drug  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google